6-Chloro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine, 97%, 1g

4-bromo-2,5-dimethoxybenzaldehyde, 95.0%, 25g

Rociletinib, 99%, 50mg

(S)-(+)-1-Cyclohexylethylamine>98.0%(GC)(T)5g

3-Oxa-9-azaspiro[5.5]undecane, 95.0%, 1g

(2,5-Dibromopyridin-4-yl)boronic acid, 95.0%, 5g

1,4-Bis(tert-butoxycarbonyl)-2-methylpiperazine-2-carboxylic acid, 98%, 1g

(4-(1-Cyanocyclopropyl)phenyl)boronic acid, 95.0%, 10g

5-Amino-3-bromo-2-chloropyridine, 98.0%, 25g

Methyl 3,5-dimethoxybenzoate, 98.0%, 100g

N-((2S,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide, 98%, 1g

Methyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate, 95.0%, 1g

(R)-2-(1-amino-2-hydroxyethyl)-5-fluorophenol hydrochloride, 98%, 100mg